Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated intranasal oxytocin in adults with Prader-Willi syndrome
2013-004437-33Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin in Prader-Willi syndrome (PWS) (3 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Behavior rating scales. Started Sep 2015; status: completed.
02
Drugs
oxytocin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on 2013-004437-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004437-33.